Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase

Multiple sclerosis (MS) is a chronic autoimmune disease driven by T and B lymphocytes. The remyelination failure and neurodegeneration results in permanent clinical disability in MS patients. A desirable therapy should not only modulate the immune system, but also promote neuroprotection and remyeli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Wenlin, Luo, Qinghua, Menger, Michael D., Fassbender, Klaus, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716455/
https://www.ncbi.nlm.nih.gov/pubmed/34975892
http://dx.doi.org/10.3389/fimmu.2021.792465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716455/
https://www.ncbi.nlm.nih.gov/pubmed/34975892
http://dx.doi.org/10.3389/fimmu.2021.792465

Ejemplares similares